Amgen (AMGN) Buildings (2009 - 2022)
Amgen (AMGN) posted quarterly Buildings of $4.2 billion for Q4 2022, up 4.29% year-over-year from $4.0 billion in Q4 2021, and up 4.29% quarter-over-quarter from $4.0 billion in Q4 2021.
Amgen (AMGN) Buildings (2009 - 2022) Analysis & Trends
Amgen's Buildings history runs 14 years deep, the most recent figure standing at $4.2 billion for Q4 2022.
- In Q4 2022, Buildings rose 4.29% year-over-year to $4.2 billion; the TTM figure through Dec 2022 stood at $4.2 billion (up 4.29% YoY), while the FY2022 annual figure was $4.2 billion, up 4.29% from the prior year.
- Buildings for Q4 2022 stood at $4.2 billion, up from $4.0 billion in the prior quarter.
- The five-year high for Buildings was $4.2 billion in Q4 2022, with the low at $3.6 billion in Q4 2018.
- The 5-year median for Buildings is $3.9 billion (2020), against an average of $3.9 billion.
- The sharpest annual moves came in 2020 and 2021: Buildings advanced 2.66% in 2020, then rose 4.43% in 2021.
- Amgen's Buildings stood at $3.6 billion in 2018, then advanced by 3.9% to $3.8 billion in 2019, then climbed by 2.66% to $3.9 billion in 2020, then advanced by 4.43% to $4.0 billion in 2021, then climbed by 4.29% to $4.2 billion in 2022.
- Business Quant data shows AMGN's Buildings at $4.2 billion in Q4 2022, $4.0 billion in Q4 2021, and $3.9 billion in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.20 Bn |
| Dec 31, 2021 | 4.03 Bn |
| Dec 31, 2020 | 3.86 Bn |
| Dec 31, 2019 | 3.76 Bn |
| Dec 31, 2018 | 3.62 Bn |
| Dec 31, 2017 | 3.51 Bn |
| Dec 31, 2016 | 3.64 Bn |
| Dec 31, 2015 | 3.64 Bn |
| Dec 31, 2014 | 3.61 Bn |
| Dec 31, 2013 | 3.47 Bn |
| Dec 31, 2012 | 3.51 Bn |
| Dec 31, 2011 | 3.46 Bn |
| Dec 31, 2010 | 3.39 Bn |
| Dec 31, 2009 | 3.29 Bn |